142 related articles for article (PubMed ID: 7697626)
1. Cytogenetic findings in regressing skin lesions of lymphomatoid papulosis.
Peters K; Knoll JH; Kadin ME
Cancer Genet Cytogenet; 1995 Mar; 80(1):13-6. PubMed ID: 7697626
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey.
Baykal C; Kılıç Sayar S; Yazganoğlu KD; Büyükbabani N
Turk J Haematol; 2021 Feb; 38(1):49-56. PubMed ID: 33389922
[TBL] [Abstract][Full Text] [Related]
3. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
4. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
5. Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.
Wieser I; Oh CW; Talpur R; Duvic M
J Am Acad Dermatol; 2016 Jan; 74(1):59-67. PubMed ID: 26518172
[TBL] [Abstract][Full Text] [Related]
6. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Herbst H; Sander C; Tronnier M; Kutzner H; Hügel H; Kaudewitz P
Br J Dermatol; 1997 Nov; 137(5):680-6. PubMed ID: 9415224
[TBL] [Abstract][Full Text] [Related]
7. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
[TBL] [Abstract][Full Text] [Related]
8. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
[TBL] [Abstract][Full Text] [Related]
9. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
Schwartz Z; Bowe RB; Coleman M; Magro CM
Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
[TBL] [Abstract][Full Text] [Related]
10. Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
Harvell J; Vaseghi M; Natkunam Y; Kohler S; Kim Y
J Cutan Pathol; 2002 Feb; 29(2):88-92. PubMed ID: 12150138
[TBL] [Abstract][Full Text] [Related]
11. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis.
Chott A; Vonderheid EC; Olbricht S; Miao NN; Balk SP; Kadin ME
J Invest Dermatol; 1996 Apr; 106(4):696-700. PubMed ID: 8618007
[TBL] [Abstract][Full Text] [Related]
12. Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas.
Kempf W; Kazakov DV; Schärer L; Rütten A; Mentzel T; Paredes BE; Palmedo G; Panizzon RG; Kutzner H
Am J Surg Pathol; 2013 Jan; 37(1):1-13. PubMed ID: 23026936
[TBL] [Abstract][Full Text] [Related]
13. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Dec; 107(6):827-32. PubMed ID: 8941669
[TBL] [Abstract][Full Text] [Related]
14. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
[TBL] [Abstract][Full Text] [Related]
15. Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin.
Steinhoff M; Hummel M; Anagnostopoulos I; Kaudewitz P; Seitz V; Assaf C; Sander C; Stein H
Blood; 2002 Jul; 100(2):578-84. PubMed ID: 12091351
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
17. CD30-Positive Lymphoproliferative Disorders.
Nikolaenko L; Zain J; Rosen ST; Querfeld C
Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
[TBL] [Abstract][Full Text] [Related]
18. Lymphomatoid papulosis type A: clinical, morphologic, and immunophenotypic study.
Sioutos N; Asvesti C; Sivridis E; Aygerinou G; Tsega A; Zakopoulou N; Zographakis I
Int J Dermatol; 1997 Jul; 36(7):514-7. PubMed ID: 9268749
[TBL] [Abstract][Full Text] [Related]
19. Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis.
Cordel N; Tressières B; D'Incan M; Machet L; Grange F; Estève É; Dalac S; Ingen-Housz-Oro S; Bagot M; Beylot-Barry M; Joly P;
Oncologist; 2016 Jan; 21(1):76-83. PubMed ID: 26668250
[TBL] [Abstract][Full Text] [Related]
20. CD30+ lymphoproliferative disorder with spindle-cell morphology.
Martires KJ; Cohen BE; Cassarino DS
J Cutan Pathol; 2016 Nov; 43(11):1041-1044. PubMed ID: 27433975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
